We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Europe Exhibits New Products and Innovative Concepts in Infection Diagnostics at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 11 Apr 2022
Print article
Image: XQ-320 hematology analyzer (Photo courtesy of Sysmex Europe)
Image: XQ-320 hematology analyzer (Photo courtesy of Sysmex Europe)

Sysmex Europe (Norderstedt, Germany) presented new products and innovative concepts in infection diagnostics at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place in Munich, Germany, from 10 to 14 April 2022. In addition to presenting its latest products at the exhibition on a spacious booth, Sysmex Europe underpinned its role as a leading solution and knowledge provider by hosting three educational workshops, plus a variety of further live sessions in a dedicated presentation area.

Sysmex Europe continued supporting the event as a gold sponsor. With a two-storey booth of 128 m2 exhibition space on the ground floor and a further 40 m2 consulting area on the upper floor, Sysmex Europe showcased its competence in the fields of clinical value, workflow automation and digital services, including solutions for new business areas. In line with the brand’s key message of ‘Lighting the way with diagnostics’, Sysmex Europe has the laboratory as well as the clinician and patient in mind and looks at the bigger picture beyond the individual analyser. To strengthen its position further, the company aims at expanding its perception in new business areas while maintaining or increasing the level of trust and loyalty of their existing customers.

Visitors saw a range of new products and innovative concepts on the booth. Besides principal exhibits for the core lab areas such as hematology, haemostasis and urinalysis, and life science solutions for fecal testing, novel highlights were the XQ-320 hematology analyzer, the BloodScience Workcell, the latest clinical flow cytometry solution featuring the XF-1600, and the digital services Caresphere XQC and Sysmex Academy app. Sysmex Europe’s philosophy extends beyond the product itself, and knowing that support and continuous education is of equal importance for a rewarding user experience, the company hosted three 60-minute educational workshops within the congresses’ program, focusing on the clinical value of infection diagnostics from POC to hematology, lean workflow using Sysmex automation concept solutions, and smartening today’s laboratories by means of digital technology and services. To reach a wider audience, these on-site workshops were streamed live via Vimeo on the company’s LinkedIn channel.

Last but not least, an additional range of live lectures and ‘Meet the expert’ sessions including external speakers – in person or virtually – took place in loose succession on the company’s booth in the ‘live presentation area’ using a large, curved screen of approx. 7 x 2.5 m size. All sessions were recorded and are made available on the Sysmex Europe website, while some of these are being additionally shown via the livestream channel.

Related Links:
Sysmex Europe 

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
PAPP-A Test
PAPP-A Mass Units AccuBind ELISA
New
Rheumatoid Arthritis Test
Finecare RF Rapid Quantitative Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.